Aldosterone-receptor antagonism in hypertension
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
The role of the renin-angiotensin-aldosterone system (RAAS) in hypertension has since long been recognized and aldosterone has been acknowledged as one of the key hormones in the pathophysiology, not only in primary aldosteronism but also in essential hypertension and drug-resistant hypertension. Aldosterone-receptor antagonists (ARAs) are increasingly used in patients with resistant hypertension, often with impressive results. However, definitive evidence for the benefit of ARAs in these patients from randomized, controlled trials is lacking. This review gives an overview of the current data on this topic. Future studies should focus on the identification of factors that are able to predict the response to treatment, as to select patients who will benefit most from treatment with ARAs. On the basis of the current knowledge, we recommend prescription of ARAs to patients with primary aldosteronism, resistant hypertension and patients with hypertension and hypokalemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pitt, B., Remme, W., Zannad, F., Neaton, J., Martinez, F., Roniker, B., Bittman, R., Hurley, S., Kleiman, J., & Gatlin, M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030207 · Cited by 4,941
Laurent, S., Boutouyrie, P., Asmar, R., Gautier, I., Laloux, B., Guize, L., Ducimetiere, P., & Benetos, A. (2001) · Hypertension · doi:10.1161/01.hyp.37.5.1236 · Cited by 3,856
A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
Rossi, G. P., Bernini, G., Caliumi, C., Desideri, G., Fabris, B., Ferri, C., Ganzaroli, C., Giacchetti, G., Letizia, C., Maccario, M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.059 · Cited by 1,467
Fardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Rise in plasma concentration of aldosterone during long-term angiotensin II suppression
STAESSEN, J., LIJNEN, P., FAGARD, R., VERSCHUEREN, L. J., & AMERY, A. (1981) · Journal of Endocrinology · doi:10.1677/joe.0.0910457 · Cited by 339
Gallay, B. J., Ahmad, S., Xu, L., Toivola, B., & Davidson, R. C. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80117-7 · Cited by 304
Štrauch, B., Zelinka, T., Hampf, M., Bernhardt, R., & Widimsky, J. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001554 · Cited by 237
Schwartz, G. L., & Turner, S. T. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.041780 · Cited by 221
NISHIZAKA, M., PRATTUBUNAMA, M., ZAMAN, M., COFIELD, S., & CALHOUN, D. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.01.002 · Cited by 146
Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure
Shah, N. C., Pringle, S. D., Donnan, P. T., & Struthers, A. D. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3282e9a72d · Cited by 43
Cited by
Hypertension: Renin–Angiotensin–Aldosterone System Alterations
te Riet, L., van Esch, J. H. M., Roks, A. J. M., van den Meiracker, A. H., & Danser, A. H. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.303587 · Cited by 706
Self-citationThe renin-angiotensin-aldosterone system and its suppression
Ames, M. K., Atkins, C. E., & Pitt, B. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15454 · Cited by 433
Václavík, J., Sedlák, R., Plachý, M., Navrátil, K., Plášek, J., Jarkovský, J., Václavík, T., Husár, R., Kociánová, E., & Táborský, M. (2011) · Hypertension · doi:10.1161/hypertensionaha.111.169961 · Cited by 308
Aldosterone Synthase Inhibition in Hypertension
Andersen, K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0379-7 · Cited by 12
Keegan, M. T. (2019) · Pharmacology and Physiology for Anesthesia · doi:10.1016/b978-0-323-48110-6.00036-3 · Cited by 11
Metadata
- Authors
- Jansen, P. M., Danser, A. J., Imholz, B. P., & van den Meiracker, A. H.
- Venue
- Journal of Hypertension
- Published
- 2009-04
- Volume
- 27
- Issue
- 4
- Pages
- 680-691
- ISSN
- 0263-6352 (ISSN-L)
- OpenAlex
- W2016325418
- Cited by
- 90
- References
- 10
- FWCI
- 9.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Aldosterone-receptor antagonism in hypertension. https://app.cochat.ai/papers/10.1097/hjh.0b013e32832810ed
- The paper
- Jansen, P. M., Danser, A. J., Imholz, B. P., & van den Meiracker, A. H. (2009). Aldosterone-receptor antagonism in hypertension. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e32832810ed
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.